Dynamic Simulations of Pathways Downstream of ERBB-Family: Exploration of Parameter Space and Effects of Its Variation on Network Behavior
暂无分享,去创建一个
Raffaele Pesenti | Silvio Parodi | Lorenzo Tortolina | Nicoletta Castagnino | Alberto Ballestrero | Franco Patrone | Cristina De Ambrosi | Eva Moran | Alessio Nencioni | R. Pesenti | L. Tortolina | N. Castagnino | A. Ballestrero | F. Patrone | S. Parodi | E. Moran | A. Nencioni | C. D. Ambrosi
[1] C. Downes,et al. PTEN function: how normal cells control it and tumour cells lose it. , 2004, The Biochemical journal.
[2] B. Kholodenko,et al. Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses , 2007, Molecular systems biology.
[3] G. Parmigiani,et al. A multidimensional analysis of genes mutated in breast and colorectal cancers. , 2007, Genome research.
[4] D. Lauffenburger,et al. Input–output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data , 2009, Molecular systems biology.
[5] S. Orsulic,et al. E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. , 1999, Journal of cell science.
[6] H V Westerhoff,et al. Why cytoplasmic signalling proteins should be recruited to cell membranes. , 2000, Trends in cell biology.
[7] J. Weinstein,et al. Depicting combinatorial complexity with the molecular interaction map notation , 2006, Molecular systems biology.
[8] Uri Alon,et al. An Introduction to Systems Biology , 2006 .
[9] S Parodi,et al. Dynamic simulations of pathways downstream of ERBB-family, including mutations and treatments: concordance with experimental results. , 2010, Current cancer drug targets.
[10] J. Tyson,et al. Chemical kinetic theory: understanding cell-cycle regulation. , 1996, Trends in biochemical sciences.
[11] Raffaele Pesenti,et al. Simulations of the EGFR - KRAS - MAPK Signalling Network in Colon Cancer. Virtual Mutations and Virtual Treatments with Inhibitors Have More Important Effects Than a 10 Times Range of Normal Parameters and Rates Fluctuations , 2009, CIBB.
[12] G. Hampton,et al. A phosphoproteomic analysis of the ErbB2 receptor tyrosine kinase signaling pathways. , 2006, Biochemistry.
[13] A. Barabasi,et al. Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.
[14] Boris N Kholodenko,et al. Scaffolding Protein Grb2-associated Binder 1 Sustains Epidermal Growth Factor-induced Mitogenic and Survival Signaling by Multiple Positive Feedback Loops* , 2006, Journal of Biological Chemistry.
[15] D. Lauffenburger,et al. Physicochemical modelling of cell signalling pathways , 2006, Nature Cell Biology.
[16] G. Parmigiani,et al. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.
[17] B. Kholodenko,et al. Quantification of Short Term Signaling by the Epidermal Growth Factor Receptor* , 1999, The Journal of Biological Chemistry.
[18] Igor Goryanin,et al. The impact of the regulatory design on the response of epidermal growth factor receptor‐mediated signal transduction towards oncogenic mutations , 2007, The FEBS journal.
[19] B N Kholodenko,et al. Signal processing at the Ras circuit: what shapes Ras activation patterns? , 2004, Systems biology.